Developing Small-Molecule Drugs for Epigenetic Treatments of Psychiatric Disorders
Time: 2:45 pm
day: Day One
Details:
- Rationalizing the use of small-molecule compounds to target metabolicepigenetic pathways in the brain
- Blocking a metabolic enzyme controls the epigenetic encoding of maladaptive memory
- Preclinical models to develop epigenetic therapeutics for neuropsychiatric disorders
Philipp Mews" alt="Philipp Mews" itemprop="image">